The role of proactive therapeutic drug monitoring in guiding infliximab therapeutic optimization in pediatric patients with Crohn's disease: A retrospective study

Documenti analoghi

• Proactive therapeutic drug monitoring and vedolizumab dose optimization in children with inflammatory bowel disease
  di: Patrick Rowland, et al.
  Pubblicazione: (2024)
• Efficacy of infliximab after loss of response of/intolerance to adalimumab in pediatric Crohn's disease: A retrospective multicenter cohort study of the “GETAID pédiatrique”
  di: Anne Lecoutour, et al.
  Pubblicazione: (2024)
• North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the therapeutic drug monitoring in pediatric inflammatory bowel disease
  di: Lina M. Felipez, et al.
  Pubblicazione: (2025)
• Evaluating the impact of therapeutic drug monitoring strategies on clinical outcomes in paediatric inflammatory bowel disease
  di: Karlotta Pauline Hubert, et al.
  Pubblicazione: (2026)
• Eosinophilic esophagitis associated with infliximab therapy in pediatric patients with inflammatory bowel disease
  di: Meng‐Che Wu, et al.
  Pubblicazione: (2025)